QA: Bristol Myers Squibb CO in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000014272_2022_Bristol_Myers_Squibb_CO.pdf

Logs

Graph

Absolute values for 0000014272, Bristol Myers Squibb CO

  xvar xval
0 AssetsCurrent 33,262,000,000
1 IntangibleAssetsNetIncludingGoodwill 63,029,000,000
2 PropertyPlantAndEquipmentNet 6,049,000,000
3 remainder_Assets 6,974,000,000
4 LiabilitiesCurrent 21,868,000,000
5 LiabilitiesNoncurrent 46,939,000,000
6 remainder_Liabilities 4,501,000,000
7 CostOfGoodsAndServicesSold 10,160,173,443
8 SellingGeneralAndAdministrativeExpense 7,690,393,326
9 ResearchAndDevelopmentExpense 11,334,227,079
10 remainder_Expenses 13,744,001,822
11 remainder_Revenues 47,297,343,482
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -16,854,262
  yvar yval
0 Assets 109,314,000,000
1 Liabilities 73,308,000,000
2 Expenses 42,928,795,670
3 Revenues 47,297,343,482
4 StockholdersEquity 36,006,000,000
5 NetIncome 4,368,547,812
6 ComprehensiveNetIncome 4,360,120,681
7 BaseVar 136,432,496,707
8 EconomicCapitalRatiobeforeLimitedLiability 0.907
9 EconomicCapitalRatio 2.23

Edgar->Model Mapping

Feature Distribution

Change over Time